Difficulty: Medium
Average Score: 94%
Practice
Principal aim for treatment of Parkinsonian disorders is:
Correct answer
B
Rationale
The correct answer is B because the principal aim for treating Parkinsonian disorders is to restore dopaminergic activity with levodopa and dopamine agonists. This is because Parkinson's disease is primarily caused by a deficit of dopamine in the brain. Levodopa is converted to dopamine in the brain, helping to alleviate symptoms.
Choice A is incorrect because antimuscarinic drugs target the cholinergic system, not the dopaminergic system, and are not the primary treatment for Parkinson's disease.
Choice C is incorrect because glutamate antagonists target a different neurotransmitter system and are not the mainstay of treatment for Parkinson's disease.
Choice D is incorrect because while restoring balance between cholinergic and dopaminergic influences may be important, the primary aim is to address the dopaminergic deficit.
Choice A is incorrect because antimuscarinic drugs target the cholinergic system, not the dopaminergic system, and are not the primary treatment for Parkinson's disease.
Choice C is incorrect because glutamate antagonists target a different neurotransmitter system and are not the mainstay of treatment for Parkinson's disease.
Choice D is incorrect because while restoring balance between cholinergic and dopaminergic influences may be important, the primary aim is to address the dopaminergic deficit.